Jane Street
SRNE

Jane Street’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Jane Street’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-731,024
Closed -$648K – 10495
2022
Q4 		$648K Buy
731,024
+276,282
+61% +$366K ﹤0.01% 5701
2022
Q3 		$714K Sell
454,742
-357,731
-44% -$811K ﹤0.01% 6034
2022
Q2 		$1.63M Buy
812,473
+647,064
+391% +$1.12M ﹤0.01% 4544
2022
Q1 		$386K Buy
165,409
+48,941
+42% +$153K ﹤0.01% 7946
2021
Q4 		$542K Buy
116,468
+63,179
+119% +$392K ﹤0.01% 7106
2021
Q3 		$407K Sell
53,289
-4,463
-8% -$37.8K ﹤0.01% 7657
2021
Q2 		$559K Sell
57,752
-154,849
-73% -$1.23M ﹤0.01% 7032
2021
Q1 		$1.76M Sell
212,601
-873,878
-80% -$9.23M ﹤0.01% 4272
2020
Q4 		$7.42M Buy
1,086,479
+250,679
+30% +$2.01M ﹤0.01% 1690
2020
Q3 		$9.32M Buy
835,800
+775,735
+1,291% +$7.1M 0.01% 1275
2020
Q2 		$378K Buy
60,065
+6,562
+12% +$25.1K ﹤0.01% 5492
2020
Q1 		$98K Buy
+53,503
New +$154K ﹤0.01% 4944
2019
Q4 		– Sell
-30,325
Closed -$72.3K – 5974
2019
Q3 		$65K Buy
30,325
+18,240
+151% +$42.5K ﹤0.01% 4843
2019
Q2 		$32K Buy
+12,085
New +$43.5K ﹤0.01% 4994
2017
Q3 		– Sell
-44,690
Closed -$89K – 5240
2017
Q2 		$89K Buy
+44,690
New +$87.2K ﹤0.01% 4179
2014
Q3 		– Sell
-18,974
Closed -$128K – 3206
2014
Q2 		$128K Sell
18,974
-47,364
-71% -$357K ﹤0.01% 2319
2014
Q1 		$850K Buy
+66,338
New +$734K 0.01% 1094

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Jane Street's SRNE Position: Q1 2023 in Review

Jane Street sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 731,024 shares — an estimated $648K sold.

Jane Street first reported a position in SRNE in Q1 2014 and held it in 17 quarters. The position peaked at $9.32M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Jane Street reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 731,024 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $648K.
  • Jane Street first reported a position in Sorrento Therapeutics, Inc. in Q1 2014 and held it in 17 quarters.
  • Jane Street's Sorrento Therapeutics, Inc. position peaked at $9.32M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.